WaradyB.A., SchaeferF., HollowayM., AlexanderS., KandertM., PirainoB.on behalf of the International Society for Peritoneal Dialysis (ISPD) Advisory Committee on Peritonitis Management in Pediatric Patients. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis.Perit Dial Int2000; 20: 610–24.
2.
WaradyB.A., BakkalogluS., NewlandJ., CantwellM., VerrinaE., NeuA.Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.Perit Dial Int2012; 32(Suppl 2): S29–86.
3.
PirainoB., BernardiniJ., BrownE., FigueiredoA., JohnsonD.W., LyeW.C.ISPD position statement on reducing the risks of peritoneal dialysis–related infections.Perit Dial Int2011; 31: 614–30.
4.
ZurowskaA., FenebergR., WaradyB.A., ZimmeringM., MonteverdeM., TestaS.Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.Am J Kidney Dis2008; 51: 455–62.
5.
SchaeferF., KlausG., Müller-WiefelD.E., MehlsO.Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).J Am Soc Nephrol1999; 10: 136–45.
6.
ZanettiG., BallyF., GreubG., GarbinoJ., KingeT., LewD.on behalf of the Cefepime Study Group. Cefepime versus imipenem–cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multi-center, evaluator-blind, prospective, randomized study.Antimicrob Agents Chemother2003; 47: 3442–7.
7.
MilesR., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients.Kidney Int2009; 76: 622–8.
8.
ChangT.I., KimH.W., ParkJ.T., LeeD.H., LeeJ.H., YooT.H.Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center.Perit Dial Int2011; 31: 60–6.
9.
WilliamsA.J., BoletisI., JohnsonB.F., RafteryA.T., CohenG.L., MoorheadP.J.Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.Perit Dial Int1989; 9: 65–7.
10.
KlausG., SchäferF., QuerfeldU., SoergelM., WolfS., MehlsO.Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.Adv Perit Dial1992; 8: 302–5.
11.
ZorzanelloM.M., FlemingW.J., ProwantB.E.Use of tissue plasminogen activator in peritoneal dialysis catheters: a literature review and one center's experience.Nephrol Nurs J2004; 31: 534–7.
12.
CobanE., OzdoganM., TuncerM., BozcukH., ErsoyF.The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis–related peritonitis.J Nephrol2004; 17: 427–30.
